Forskning
Udskriv Udskriv
Switch language
Rigshospitalet - en del af Københavns Universitetshospital
E-pub ahead of print

Selective serotonin reuptake inhibitors are still harmful and ineffective. Responses to the comments by Hieronymus et al

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Harvard

APA

CBE

MLA

Vancouver

Author

Bibtex

@article{a8bb92d1d02c466799ad466f9fb3ebd7,
title = "Selective serotonin reuptake inhibitors are still harmful and ineffective. Responses to the comments by Hieronymus et al",
abstract = "In this response, we address point by point the additional issues raised by Hieronymus et al. in their second round of critique of our systematic review on selective serotonin reuptake inhibitors for major depression. We repulse that we are biased or mistaken in any major ways. We acknowledge that we missed a few small, mostly unpublished trials, and we made a few minor errors in our systematic review. However, these omissions and errors neither have any impact on our overall results nor on our conclusions. The critique by Hieronymus et al.seem to raise questions about their understanding of the systematic review process and, on several occasions, they wrongly claimed that we made errors. Our analyses should be impartial and free from any biases or prejudices as we do not have any obligation to support the interests of sponsors or other groups.",
author = "{Kiran Kumar}, Katakam and {Naqash Javaid}, Sethi and {Janus Christian}, Jakobsen and Gluud Christian",
year = "2019",
month = "6",
day = "24",
doi = "10.1017/neu.2019.24",
language = "English",
pages = "1--28",
journal = "Acta Neuropsychiatrica (Online)",
issn = "1601-5215",
publisher = "Wiley-Blackwell Publishing, Inc",

}

RIS

TY - JOUR

T1 - Selective serotonin reuptake inhibitors are still harmful and ineffective. Responses to the comments by Hieronymus et al

AU - Kiran Kumar, Katakam

AU - Naqash Javaid, Sethi

AU - Janus Christian, Jakobsen

AU - Christian, Gluud

PY - 2019/6/24

Y1 - 2019/6/24

N2 - In this response, we address point by point the additional issues raised by Hieronymus et al. in their second round of critique of our systematic review on selective serotonin reuptake inhibitors for major depression. We repulse that we are biased or mistaken in any major ways. We acknowledge that we missed a few small, mostly unpublished trials, and we made a few minor errors in our systematic review. However, these omissions and errors neither have any impact on our overall results nor on our conclusions. The critique by Hieronymus et al.seem to raise questions about their understanding of the systematic review process and, on several occasions, they wrongly claimed that we made errors. Our analyses should be impartial and free from any biases or prejudices as we do not have any obligation to support the interests of sponsors or other groups.

AB - In this response, we address point by point the additional issues raised by Hieronymus et al. in their second round of critique of our systematic review on selective serotonin reuptake inhibitors for major depression. We repulse that we are biased or mistaken in any major ways. We acknowledge that we missed a few small, mostly unpublished trials, and we made a few minor errors in our systematic review. However, these omissions and errors neither have any impact on our overall results nor on our conclusions. The critique by Hieronymus et al.seem to raise questions about their understanding of the systematic review process and, on several occasions, they wrongly claimed that we made errors. Our analyses should be impartial and free from any biases or prejudices as we do not have any obligation to support the interests of sponsors or other groups.

U2 - 10.1017/neu.2019.24

DO - 10.1017/neu.2019.24

M3 - Journal article

SP - 1

EP - 28

JO - Acta Neuropsychiatrica (Online)

JF - Acta Neuropsychiatrica (Online)

SN - 1601-5215

ER -

ID: 57627000